Cardinal Infrastructure Group has completed the acquisition of Allied Paving Contractors, expanding its self-performing paving capabilities in the Atlanta area. Allied, which generated about $100 million in standalone revenue, will now contribute to Cardinal's margin through work on Cardinal projects. This move allows Cardinal to streamline project timelines by sequencing paving work directly after grading and site development, enhancing service efficiency. Allied's CEO, John McLean, will join Cardinal's leadership to oversee paving operations in Georgia, aligning with Cardinal's strategy to acquire founder-led companies and grow its market presence in the Southeast.
Cardinal Infrastructure Group's acquisition of Allied Paving Contractors is the subject, with Pluang's Industrials sector data providing market context. As of Oct 02, 2026 02:51 WIB, out of 93 priced Industrials-sector US stocks tradable on Pluang, 69 rose and 24 fell. Notable movers include nVent Electric (NVT) at USD 165.79 with a 3.38% increase and 100% buy order activity, Hubbell (HUBB) at USD 468.44 with a 3.27% rise but 100% sell order activity, and Quanta Services Inc (PWR) at USD 663.31 with a 3.25% gain and 70% buy order activity. The most notable figure is nVent Electric's 3.38% price increase.
Wells Fargo initiated coverage on BlackRock with an 'Overweight' rating, highlighting it as a good entry point for investors. Analysts expect BlackRock's Q3 earnings per share to rise to $14.25 from $11.55 a year ago, with revenue projected at $7.56 ...
Nike reported earnings per share of $0.48, beating estimates, but revenue fell short at $11.21 billion due to weak demand in Greater China and rising competition. The company issued a cautious fiscal 2027 outlook with EPS forecast between $1.15 and $...
NETSOL Technologies reported a record $20.7 million revenue in fiscal 2026 Q4, with net income rising 45.9% to $3.8 million. The company improved its gross margin to 63.6% and operating margin to 21.6%, reflecting enhanced profitability. For fiscal 2...
On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...
Jefferies analyst Roger Song set a $150 price target for Nektar Therapeutics, suggesting a 219% upside from its $46.99 trading price. This comes after Nektar presented positive six-month Phase IIb trial results for its alopecia drug REZPEG, which als...
